Rehmann Capital Advisory Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $456K | Sell |
|
|||||
|
2024
Q4 | $468K | Sell |
|
|||||
|
2024
Q3 | $458K | Sell |
|
|||||
|
2024
Q2 | $725K | Sell |
|
|||||
|
2024
Q1 | $771K | Sell |
|
|||||
|
2023
Q4 | $624K | Sell |
|
|||||
|
2023
Q3 | $628K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $822K | Sell |
|
|||||
|
2022
Q4 | $750K | Buy |
|
|||||
|
2022
Q3 | $805K | Buy |
|
|||||
|
2022
Q2 | $916K | Buy |
|
|||||
|
2022
Q1 | $1.07M | Buy |
|
|||||
|
2021
Q4 | $1.17M | Sell |
|
|||||
|
2021
Q3 | $1.12M | Sell |
|
|||||
|
2021
Q2 | $1.04M | Buy |
|
|||||
|
2021
Q1 | $832K | Buy |
|
|||||
|
2020
Q4 | $886K | Sell |
|
|||||
|
2020
Q3 | $778K | Buy |
|
|||||
|
2020
Q2 | $672K | Buy |
|
|||||
|
2020
Q1 | $598K | Buy |
|
|||||
|
2019
Q3 | $672K | Sell |
|
|||||
|
2019
Q2 | $568K | Sell |
|
|||||
|
2019
Q1 | $592K | Buy |
|
|||||
|
2018
Q4 | $471K | Buy |
|
|||||
|
2018
Q3 | $534K | Buy |
|
|||||
|
2018
Q2 | $446K | Sell |
|
|||||
|
2018
Q1 | $432K | Hold |
|
|||||
|
2017
Q4 | $349K | Buy |
|
|||||
|
2017
Q3 | $328K | Buy |
|
|||||
|
2017
Q2 | $263K | Sell |
|
|||||
|
2017
Q1 | $319K | Buy |
|
|||||
|
2016
Q4 | $313K | Buy |
|
|||||
|
2016
Q3 | $350K | Buy |
|
|||||
|
2016
Q2 | $259K | Sell |
|
|||||
|
2016
Q1 | $236K | Sell |
|
|||||
|
2015
Q4 | $222K | Buy |
|